Clinical Trials
- This forum has 719 topics, 1,624 replies, and was last updated 1 month, 2 weeks ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
-
Our New Discussion Board is HERE
1
2
Started by:
in: Announcements
- 14
- 27
- 3 months, 3 weeks ago
- INCB 54828 1 2 … 4 5
- 14
- 63
- 1 year, 2 months ago
- Update on NIH Trial 1 2 … 6 7
- 20
- 93
- 2 years, 9 months ago
- Agios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial 1 2 … 6 7
- 15
- 98
- 3 years, 1 month ago
- Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage re
- 2
- 2
- 2 weeks, 6 days ago
- Phase I study (PAYLOAD) of RRx-001 + irinotecan in patients with advanced solid
- 1
- 1
- 1 month, 2 weeks ago
- A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2
- 1
- 1
- 1 month, 2 weeks ago
- First-in-human (FIH) phase I study of GST-HG161, a potent and highly selective c
- 1
- 1
- 1 month, 2 weeks ago
- Safety and feasibility of systemic anticancer therapy in gastrointestinal (GI) c
- 1
- 1
- 1 month, 2 weeks ago
- Phase I study of rucaparib and irinotecan in advanced solid tumors with homologo
- 1
- 1
- 1 month, 2 weeks ago
- Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every t
- 1
- 1
- 1 month, 2 weeks ago
- Pilot study on outcome and antitumor efficacy of an autologous cancer cell vacci
- 1
- 1
- 1 month, 2 weeks ago
- Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid
- 1
- 1
- 1 month, 2 weeks ago
- Immune activation in first-in-human anti-macrophage antibody (anti-Clever-1 mAb;
- 1
- 1
- 1 month, 2 weeks ago
- A phase II study of selective HDAC6 inhibition with KA2507 for second-line treat
- 1
- 1
- 1 month, 2 weeks ago
- Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liv
- 1
- 1
- 1 month, 2 weeks ago
-
Our New Discussion Board is HERE
1
2
- You must be logged in to create new topics.